Applicability of the Rockall score in patients undergoing endoscopic therapy for upper gastrointestinal bleeding

Autor: Bessa, X., O’Callaghan, E., Ballesté, B., Nieto, M., Seoane, A., Panadès, A., Vazquez, D.J., Andreu, M., Bory, F.

Publikováno v: In Digestive and Liver Disease 2006 38(1):12-17

Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients

Autor: Gisbert JP, Pérez-Aisa A, Bermejo F, Castro-Fernández M, Almela P, Barrio J, Cosme A, Modolell I, Bory F, Fernández-Bermejo M, Rodrigo L, Ortuño J, Sánchez-Pobre P, Khorrami S, Franco A, Tomas A, Guerra I, Lamas E, Ponce J, Calvet X

Publikováno v: JOURNAL OF CLINICAL GASTROENTEROLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Second-line bismuth-containing quadruple therapy is complex and frequently induces adverse effects. A triple rescue regimen containing levofloxacin is a potential alternative; however, resistance to quinolones is rapidly increasing.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::9db63d31e8bc0a33c6168b3a087de082
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1611

Role of Helicobacter pylori in stomach cancer after partial gastrectomy for benign ulcer disease

Autor: Seoane, A., Bessa, X., Alameda, F., Munné, A., Gallen, M., Navarro, S., O'Callaghan, E., Panadès, A., Andreu, M., Bory, F.

Publikováno v: Revista Española de Enfermedades Digestivas, Volume: 97, Issue: 11, Pages: 778-785, Published: NOV 2005

Objective: to determine the prevalence of Helicobacter pylori infection in patients having undergone gastrectomy for non-neoplastic disease who later developed gastric stump cancer. Material and methods: retrospective study of all patients with parti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______624::354ec4b3017b18c0a5d9727365a69069
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082005001100002&lng=en&tlng=en

SAT-462 - Enhanced Liver Fibrosis (ELF) Test Quantification in HBeAg-Negative Patients with Nucleos(T)Ide Analogues 1, 3, 5 and 8 Years after Liver Biopsy

Autor: Puigvehí, M., Broquetas, T., García-Retortillo, M., Hernández, J.J., Fernández, R., Cañete, N., Coll, S., Cabrero, B., Gimeno, J., Giménez, M.D., Bory, F., Solà, R., Carrión, J.A.

Publikováno v: In Journal of Hepatology 2016 64(2) Supplement:S730-S730

THU-164 - Quantification of HBsAg (HBsAg-Q) in HBeAg-Negative Patients Receiving Nucleos(T)ide Analogues to Predict the Loss of HBsAg

Autor: Broquetas, T., García-Retortillo, M., Hernández, J.J., Puigvehí, M., Fernández, R., Cañete, N., Coll, S., Cabrero, B., Giménez, M.D., Bory, F., Solà, R., Carrión, J.A.

Publikováno v: In Journal of Hepatology 2016 64(2) Supplement:S379-S379